Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trials.

Flaherty LE, Atkins M, Sosman J, Weiss G, Clark JI, Margolin K, Dutcher J, Gordon MS, Lotze M, Mier J, Sorokin P, Fisher RI, Appel C, Du W
J Clin Oncol. 2001 19 (13): 3194-202

PMID: 11432886 · DOI:10.1200/JCO.2001.19.13.3194

MeSH Terms (17)

Adult Aged Ambulatory Care Antineoplastic Combined Chemotherapy Protocols Cisplatin Dacarbazine Disease-Free Survival Female Humans Interferon-alpha Interferon alpha-2 Interleukin-2 Male Melanoma Middle Aged Recombinant Proteins Survival Rate

Connections (1)

This publication is referenced by other Labnodes entities: